:::LALKAR GROUP::::

Sudarshan Pharma Industries Ltd

Registered Office: 301 3rd Floor Aura Biplex,SV Road Borivali(West), Mumbai - 400092, Maharashtra, India.
Phone : 91-22-42221111 Fax:
Email : compliance.spil@gmail.com
Website : www.sudarshanpharma.com

Public issue of 68,62,400 equity shares of face value of Rs. 10.00 each ("Equity Shares") of Sudarshan Pharma Industries Limited (the "Company" or the "Issuer") for cash at a price of Rs. 73.00 per equity share including a share premium of Rs. 63.00 per equity share (the "Issue Price") aggregating to Rs. 50.10 crores ("The Issue") of which 3,44,000 equity shares aggregating to Rs. 2.51 crores will be reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e. net issue of 65,18,400 equity shares aggregating to Rs. 47.59 crores (the "Net Issue"). The issue and the net issue will constitute 28.52% and 27.09% respectively of the post issue paid-up equity share capital of the company. Issue Price : Rs. 73 per equity share of face value of Rs. 10 each. Anchor Investor Issue Price : Rs. 73 per equity shares The issue price is 7.3 times of the face value. Bids can be made for a minimum of 1600 equity shares and in multiples of 1600 equity shares thereafter.

Issue		Money Payable On
Opens On	Closes On	Application	Allotment
09-Mar-23	14-Mar-23	73.00-0.00	0.00-0.00

Minimum Application for shares in Nos : 1600 Further Multiples of : 1600

	(Rs)	Lead Managers to the Issue
Project Cost	42.20	Gretex Corporate Services Ltd
Project Financed through Current Offer	50.10
Post Issue Equity Share Capital	24.07
Issue Price	73.00

Projects

Working Capital Requirements

General Corporate Purposes

Promoted By

Hemal Vasantrai Mehta

Sachin Vasantrai Mehta

Listing At

BSE - SME

Registrar to the Issue

No Data Available